Curis (CRIS) Treasury Shares (2010 - 2026)
Curis' (CRIS) quarterly Treasury Shares came in at $1.5 million in Q4 2017, little changed YoY from $1.5 million in Q4 2016, and little changed on a QoQ basis from $1.5 million in Q3 2017.
Curis (CRIS) Treasury Shares (2010 - 2026) Analysis & Trends
Curis (CRIS) has 8 years of Treasury Shares data on file, last reported at $1.5 million in Q4 2017.
- Quarterly Treasury Shares changed 0.0% year-over-year to $1.5 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $1.5 million (changed 0.0% YoY) and the FY2017 annual result came in at $1.5 million, changed 0.0% from the prior year.
- Treasury Shares steadied at $1.5 million in Q4 2017, from $1.5 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $330500.0 in Q1 2025 to a low of $40137.0 in Q2 2024.
- A 4-year average of $130916.1 and a median of $112500.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2013 — Treasury Shares dropped 29.01% — and 2014, when it jumped 140.86%.
- Tracing CRIS's Treasury Shares over 5 years: stood at $632755.0 in 2013, then jumped by 140.86% to $1.5 million in 2014, then decreased by 0.0% to $1.5 million in 2015, then changed by 0.0% to $1.5 million in 2016, then changed by 0.0% to $1.5 million in 2017.
- The last three Treasury Shares figures came in at $1.5 million (Q4 2017), $1.5 million (Q3 2017), and $1.5 million (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 2.72 Mn |
| 10 | Curis | 3.33 Mn | -2.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,350.00 |
| Mar 31, 2026 | 148,350.00 |
| Dec 31, 2025 | 257,400.00 |
| Dec 31, 2025 | 257,400.00 |
| Mar 31, 2025 | 330,500.00 |
| Mar 31, 2025 | 330,500.00 |
| Dec 31, 2024 | 40,137.00 |
| Dec 31, 2024 | 40,137.00 |
| Sep 30, 2024 | 40,137.00 |
| Sep 30, 2024 | 40,137.00 |
| Jun 30, 2024 | 40,137.00 |
| Jun 30, 2024 | 40,137.00 |
| Mar 31, 2024 | 110,500.00 |
| Mar 31, 2024 | 110,500.00 |
| Dec 31, 2023 | 110,500.00 |
| Dec 31, 2023 | 110,500.00 |
| Sep 30, 2023 | 114,500.00 |
| Sep 30, 2023 | 114,500.00 |
| Jun 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 117,000.00 |